Nuplazid 34 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQWK8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,771
Award facts
- Contract value 100% obligated
- $11,771.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11.77K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in quantities of 30. The award, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order falls under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for the Department of Defense's global pharmaceutical supply requirements.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V contract designated SPE2DR, valued at $499.99M with a completion date of December 31, 2036, which authorizes the Defense Logistics Agency to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. The company's substantial federal contracting activity and demonstrated performance across multiple therapeutic categories position it as a critical supplier within the Department of Defense pharmaceutical supply chain. This particular delivery order for Nuplazid, an antipsychotic medication, represents routine pharmaceutical procurement executed through the established prime vendor framework to support ongoing military medical operations.
Quick answers
Who was awarded contract SPE2DR26FQWK8?
SPE2DR26FQWK8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FQWK8 worth?
The government has obligated $11,771 on SPE2DR26FQWK8.
Is contract SPE2DR26FQWK8 an order under another contract?
Yes. SPE2DR26FQWK8 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWK8 competed?
The extent of competition for SPE2DR26FQWK8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award